Rajeev Mathew

Oxford, ENG, GB 
Oxford, ENG, GB 

Overview

Rajeev Mathew practices practicing medicine in Oxford, United Kingdom.

His clinical expertise encompasses Schwannomatosis, Anaplastic Thyroid Cancer, Schwannoma, Acoustic Neuroma, and Stent Placement.

He is actively involved in clinical research, co-authoring 14 peer reviewed articles.

Gender

Male

Locations

Oxford, ENG, United Kingdom
Other Locations
Cambridge, ENG, United Kingdom
332 Grays Inn Road, London, ENG WC1X8EE, United Kingdom
Guildford, ENG, United Kingdom

Frequently Asked Questions about Rajeev Mathew

Is Rajeev Mathew a top-rated expert for Schwannomatosis?

MediFind is an objective health platform that identifies experts based on real-world data. Rajeev Mathew is classified as an Experienced expert for Schwannomatosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Rajeev Mathew participate in research or clinical trials?

Yes. Rajeev Mathew has published 14 articles and abstracts on conditions like Schwannomatosis. You can view a list of Rajeev Mathew's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Mathew's expertise for a condition
ConditionClose
        View All 13 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile